Evidence map›Paper›PMID 26186903›Full record

ArticleJournal of neuro-oncology2015

Clinical presentation and long-term outcome of primary spinal peripheral primitive neuroectodermal tumors.

Xianzeng Tong, Xiaofeng Deng, Tao Yang, Chenlong Yang, Liang Wu, Jun Wu, Yuqiang Yao, Zhuang Fu, Shuo Wang, Yulun Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neuro-oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Primitive Neuroectodermal Tumour Invading the Inferior Vena Cava.European journal of case reports in internal medicine · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Xianzeng TongDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Xiaofeng DengDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Tao YangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Chenlong YangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Liang WuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Jun WuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Yuqiang YaoDepartment of Neurosurgery, Beijing Jishuitan Hospital, Fourth Medical College of Peking University, Beijing, 100035, China.
Zhuang FuDepartment of Neurosurgery, Beijing Jishuitan Hospital, Fourth Medical College of Peking University, Beijing, 100035, China.
Shuo WangDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China.
Yulun XuDepartment of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, 100050, China. xuhuxi@sina.com.
Capital Medical University · CNBeijing Jishuitan Hospital · CNBeijing Tian Tan Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary spinal peripheral primitive neuroectodermal tumors (pPNETs) are extremely rare entities that predominantly occur in children and young adults. Few studies have reported more than three cases. There are no current optimum treatment strategies due to the paucity of data. Here, we present 13 patients (nine females and four males) with primary intraspinal pPNETs who were surgically treated from April 2008 to February 2014. Histopathologic findings revealed the expression of CD99 in all cases. Limb weakness was the most common initial symptom (11/13, 85 %). The tumors were located mainly at the cervical level (6/13, 46 %) and in the epidural space (10/13, 77 %). The radiological diagnosis was neurinoma or meningioma in most cases (10/13, 77 %). Gross total resection was achieved in 77 % (10/13) of patients. During a mean follow-up of 25.5 months, local relapse occurred in 8 (61.5 %) patients and distant metastases occurred in 8 (61.5 %) patients. The overall 1-year survival rate was 77 % (10/13), and the overall 2-year survival rate was 54 % (7/13). The 2-year survival rate was 57.1 % in patients with adjuvant chemotherapy and 50 % in those without chemotherapy. Gross total resection and adjuvant radiotherapy with or without chemotherapy demonstrated a longer survival period (1-year survival rate: 100 %; 2-year survival rate: 86 %). Our data showed that primary spinal pPNETs are extremely rare and aggressive tumors with a poor prognosis. Radical resection is advocated. Gross total resection combined with adjuvant radiation may help to significantly improve patient survival period. Chemotherapy may also help to slightly prolong patient life.

Indexed as

Treatment Outcome12E7 AntigenAdjuvants, ImmunologicAdolescentAdultAntigens, CDCell Adhesion MoleculesChildChild, PreschoolCombined Modality TherapyFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle Aged12E7 AntigenAdjuvants, ImmunologicAntigens, CDCD99 protein, humanCell Adhesion MoleculesPrimary peripheral primitive neuroectodermal tumorsSpinal surgerySpinal tumors

Identifiers

PMID26186903
OpenAlexW910180753

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.